نتایج جستجو برای: stribild
تعداد نتایج: 25 فیلتر نتایج به سال:
INTRODUCTION Simplification to Stribild (STB) was statistically superior to continuation of a ritonavir-boosted protease inhibitor (PI+RTV) with emtricitabine and tenofovir DF (FTC/TDF) at week (W) 48 in virologically suppressed HIV adults (1). We report the W48 efficacy and safety of STB versus RTV-boosted darunavir (DRV) with FTC/TDF in suppressed subjects. MATERIAL AND METHODS Virologicall...
INTRODUCTION Cobicistat, a component of stribild (STB), is known to inhibit renal creatinine secretion. A detailed analysis of the renal safety profile of STB in two Phase 3b switch studies of virologically-suppressed individuals on stable therapy: STRATEGY(S)-PI (STB vs a RTV-boosted protease inhibitor [PI] with emtricitabine and tenofovir DF [FTC/TDF]); and STRATEGY(S)-NNRTI (STB versus a non...
PIN77 A Cost-EffECtIvENEss EvAluAtIoN for A NEw thErAPy IN hIv trEAtmENt Malhan S.1, Kockaya G.2, Elbir Zengin T.2, Dalgic C.2, Yenilmez F.B.3, Cerci P.3, Oksuz E.1, Tayfun K.2, Unal S.3 1Baskent University, Ankara, Turkey, 2Gilead Science, Istanbul, Turkey, 3Hacettepe University, Ankara, Turkey Objectives: Economical evaluation of Stribild in Turkey, which is a single tablet regimen indicated ...
Of all the antiretroviral therapy (ART) drugs in recent development, few have generated as much expectation as the HIV integrase strand transfer inhibitor dolutegravir. Raltegravir, the fi rst in this class, has proved to be a very valuable drug, from treatment initiation to late salvage. However, in an era in which once daily therapy and single tablet regimens dominate the treatment initiation...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید